Table: RaQualia Pharma -2021 parent results

RaQualia Pharma

14/02/2022 06:30

Feb 14 (Reuters)- 
          RaQualia Pharma Inc 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to     NEXT     
                Dec 31, 2021    Dec 31, 2020   Dec 31, 2022     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             2.36            1.10                                 
                (+134.0 pct)     (-40.2 pct)                             
  Operating        505 mln      loss 512 mln                             
  Recurring        656 mln      loss 550 mln                             
  Net              614 mln      loss 654 mln                             
  EPS             29.34 yen    loss 31.26 yen                            
  EPS Diluted     29.31 yen                                              
  Ann Div            NIL             NIL            NIL                  
  -Q2 Div            NIL             NIL            NIL                  
  -Q4 Div            NIL             NIL            NIL                  
  
  NOTE - RaQualia Pharma Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T